Flamel Technologies
Records under this name other than patents Flamel Technologies holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,084,045 | Pharmaceutical Formulations for the Prolonged Release of Active Principle(S) and Their Applications now held by Avadel Legacy Pharmaceuticals, LLC In force · Medium confidence | In force | Medium confidence | |
| US 8,507,003 | Compressed tablets comprising microcapsules with modified release now held by Flamel Ireland Limited In force · High confidence | In force | High confidence | |
| US 9,775,355 | Guanidine Derivative Compounds now held by Flamel Ireland Limited In force · High confidence | In force | High confidence | |
| US 9,561,179 | Controlled-Release Floating Pharmaceutical Compositions now held by Flamel Ireland Limited In force · High confidence | In force | High confidence | |
| US 9,233,993 | N-Phosphonomethylglycine Guanidine Derivative Salts now held by Flamel Ireland Limited In force · High confidence | In force | High confidence | |
| US 10,052,289 | Composition comprising an active agent with low aqueous solubility now held by Avadel Legacy Pharmaceuticals, LLC In force · High confidence | In force | High confidence | |
| US 8,652,523 | Oral Pharmaceutical Formulation in the Form of a Plurality of Microcapsules for Prolonged Release of Active Principle(S) with Slow Solubility now held by Flamel Ireland Limited Term ended Ended no later than Nov 1, 2025 · Medium confidence | Term ended | Ended no later than Nov 1, 2025 | Medium confidence |
| US 7,906,145 | Oral Pharmaceutical Formulation in the Form of Aqueous Suspension for Modified Release of Active Principle(S) now held by Avadel Legacy Pharmaceuticals, LLC Term ended Term ended Sep 26, 2025 · High confidence | Term ended | Term ended Sep 26, 2025 | High confidence |
| US 8,101,209 | Microparticulate Oral Galenical Form for the Delayed and Controlled Release of Pharmaceutical Active Principles now held by Flamel Ireland Limited Term ended Ended no later than Sep 11, 2025 · Medium confidence | Term ended | Ended no later than Sep 11, 2025 | Medium confidence |
| US 8,821,935 | Microcapsules with modified release of active principles with low solubility for oral delivery now held by Flamel Ireland Limited Term ended Ended no later than Jul 28, 2023 · Low confidence | Term ended | Ended no later than Jul 28, 2023 | Low confidence |